Ruolun Qiu

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH ₁ Antagonist) in the Treatment of Major Depression

Brendon Binneman, Douglas E. Feltner, Sheela Kolluri et al. · American Journal of Psychiatry · 2008 · 250 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Ponsegromab for the Treatment of Cancer Cachexia

John D. Groarke, Jeffrey Crawford, Susie M. Collins et al. · New England Journal of Medicine · 2024 · 240 citations · Full text

Medicine, Oncology, Pharmacology +13

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial

Seth Forman, David M. Pariser, Yves Poulin et al. · Journal of Investigative Dermatology · 2020 · 105 citations

Medicine, Pharmacology, Pharmacotherapy +14

The future is now: Model‐based clinical trial design for Alzheimer's disease

Klaus Romero, Kaori Ito, J. S. Rogers et al. · Clinical Pharmacology & Therapeutics · 2014 · 81 citations · Full text

Medicine, Pharmaceutical Policy, Pharmacology +17

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA_A receptor positive allosteric modulator PF‐06372865

Sarah A. Nickolls, Rachel Gurrell, Guido van Amerongen et al. · British Journal of Pharmacology · 2017 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15